CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

Summary

This is a Phase 2 study with primary objective of looking whether YPT-01 phage therapy reduces sputum bacterial load in cystic fibrosis subjects with Pseudomonas aeruginosa. In addition, study evaluates the safety profile of phage therapy in this patient population.

Timeline

Start

2021-03-29

Primary completion

2023-05-26

Completion

2023-06-22

Drugs

Indications